The use of formic acid to embellish amyloid plaque detection in Alzheimer's disease tissues misguides key observations

被引:39
作者
D'Andrea, MR [1 ]
Reiser, PA [1 ]
Polkovitch, DA [1 ]
Gumula, NA [1 ]
Branchide, B [1 ]
Hertzog, BM [1 ]
Schmidheiser, D [1 ]
Belkowski, S [1 ]
Gastard, MC [1 ]
Andrade-Gordon, P [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA
关键词
Alzheimer's disease; amyloid plaques; a beta 42; formic acid; immunohistochemistry; intracellular amyloid; neurons;
D O I
10.1016/S0304-3940(03)00252-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We compared our heat pretreatment method to the widely used formic acid pretreatment technique to immunohistochemically detect amyloid in control and Alzheimer's disease brain tissues. Both methods detected amyloid in plaques, neurons, ependymal cells, circulating monocytes, vascular smooth muscle and endothelial cells. Although there were no observable differences in the intensity of the amyloid labeling in these cell types using both pretreatment methods, there were considerable differences in the intensity of amyloid immunolabeling in the plaques. The formic acid produced much more intense amyloid labeling in the plaques than the heat method. With the heat method, the intensity of the amyloid labeling in the plaques was similar to that detected in nearby neurons suggesting a neuronal origin of plaques. Conversely, the intensity of the amyloid in nearby neurons and plaques was drastically different using the formic acid suggesting unique origins of amyloid. The obvious benefits of formic acid for increasing the sensitivity of amyloid plaque immunolabeling may artifactually emphasize plaques over amyloid-containing cells during analyses. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:114 / 118
页数:5
相关论文
共 19 条
[1]   FORMIC-ACID TREATMENT EXPOSES HIDDEN NEUROFILAMENT AND TAU EPITOPES IN ABNORMAL CYTOSKELETAL FILAMENTS FROM PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY AND ALZHEIMERS-DISEASE [J].
CAMMARATA, S ;
MANCARDI, G ;
TABATON, M .
NEUROSCIENCE LETTERS, 1990, 115 (2-3) :351-355
[2]   Optimization of techniques for the maximal detection and quantification of Alzheimer's-related neuropathology with digital imaging [J].
Cummings, BJ ;
Mason, AJL ;
Kim, RC ;
Sheu, PCY ;
Anderson, AJ .
NEUROBIOLOGY OF AGING, 2002, 23 (02) :161-170
[3]   Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease [J].
D'Andrea, MR ;
Nagele, RG ;
Wang, HY ;
Peterson, PA ;
Lee, DHS .
HISTOPATHOLOGY, 2001, 38 (02) :120-134
[4]   Lipofuscin and Aβ42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains [J].
D'Andrea, MR ;
Nagele, RG ;
Gumula, NA ;
Reiser, PA ;
Polkovitch, DA ;
Hertzog, BM ;
Andrade-Gordon, P .
NEUROSCIENCE LETTERS, 2002, 323 (01) :45-49
[5]   Consistent immunohistochemical detection of intracellular β-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex [J].
D'Andrea, MR ;
Nagele, RG ;
Wang, HY ;
Lee, DHS .
NEUROSCIENCE LETTERS, 2002, 333 (03) :163-166
[6]   Targeting intracellular Aβ42 for Alzheimer's disease drug discovery [J].
D'Andrea, MR ;
Lee, DHS ;
Wang, HY ;
Nagele, RG .
DRUG DEVELOPMENT RESEARCH, 2002, 56 (02) :194-200
[7]   MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in brains with Alzheimer's disease [J].
D'Andrea, MR ;
Nagele, RG .
BIOTECHNIC & HISTOCHEMISTRY, 2002, 77 (02) :95-103
[8]   Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease [J].
D'Andrea, MR ;
Reiser, PA ;
Gumula, NA ;
Hertzog, BM ;
Andrade-Gordon, P .
BIOTECHNIC & HISTOCHEMISTRY, 2001, 76 (02) :97-106
[9]  
DOIYI R, 1991, ACTA NEUROPATHOL, V82, P260, DOI 10.1007/BF00308810
[10]   Intraneuronal Aβ42 accumulation in human brain [J].
Gouras, GK ;
Tsai, J ;
Naslund, J ;
Vincent, B ;
Edgar, M ;
Checler, F ;
Greenfield, JP ;
Haroutunian, V ;
Buxbaum, JD ;
Xu, HX ;
Greengard, P ;
Relkin, NR .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (01) :15-20